Tumor necrosis factor-based isolated limb perfusion for soft tissue sarcoma and melanoma: ten years of successful antivascular therapy (Q33186052)

23 July 2017

1 reference

title

Tumor necrosis factor-based isolated limb perfusion for soft tissue sarcoma and melanoma: ten years of successful antivascular therapy (English)

1 reference

23 July 2017

1

Alexander M M Eggermont

1 reference

23 July 2017

Timo L M ten Hagen

2

1 reference

23 July 2017

1 March 2003

1 reference

23 July 2017

Current Oncology Reports

1 reference

23 July 2017

5

1 reference

23 July 2017

2

1 reference

23 July 2017

79-80

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-003-0091-x

23 July 2017

0 references

cites work

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

1 reference

12 December 2020

Low-dose tumor necrosis factor-alpha augments antitumor activity of stealth liposomal doxorubicin (DOXIL) in soft tissue sarcoma-bearing rats

1 reference

12 December 2020

Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion

1 reference

12 December 2020

Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma

1 reference

12 December 2020

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

12 December 2020

Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver

1 reference

12 December 2020

TNF is here to stay--revisited

1 reference

12 December 2020

10.1007/S11912-003-0091-X

Identifiers

DOI

1 reference

PubMed ID

12583823

Dimensions Publication ID

23 July 2017

0 references

1 reference

PubMed ID

12583823